Evoq Remedies Ltd

BSE: 543500 · Healthcare · 9 announcements

Share price: ₹1.59
Market cap: ₹3.96 Cr
Revenue (annual): ₹25.51 Cr
Net profit (annual): ₹-0.24 Cr
P/E (TTM): -16.5×Sector 53.1×
Promoter holding: 0.02%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Board Meeting Date 3 Insolvency Petition 2 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

30 May 2026 19:44 IST BSE

Financial Results

Evoq Remedies Financial Results

Evoq Remedies Limited reported audited financial results for the year ended March 31, 2026. The auditor issued a qualified opinion citing material uncertainty regarding going concern.

Read the filing ↗

30 May 2026 19:34 IST BSE

Financial Results

Evoq Remedies H2 FY26 Results: Net Loss of ₹0.3 Cr

Evoq Remedies Ltd reported a net loss of ₹0.3 Cr for H2 FY26.

Key figure: Net loss ₹0.3 Cr

Open full results → Read the filing ↗

30 May 2026 19:33 IST BSE

Financial Results

Evoq Remedies Financial Results

Evoq Remedies Limited reported annual revenue of ₹26.76 Crore for FY2026. The board also appointed M/s. Jay Pandya & Associates as secretarial auditors for FY2025-26.

Value: ₹26.76 Cr

Read the filing ↗